&Partners’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.14M Buy
32,808
+4,745
+17% +$352K 0.01% 868
2025
Q4
$2.22M Buy
28,063
+1,409
+5% +$108K 0.01% 812
2025
Q3
$1.95M Buy
26,654
+4,415
+20% +$324K 0.01% 767
2025
Q2
$1.69M Buy
22,239
+4,651
+26% +$329K 0.01% 741
2025
Q1
$1.31M Buy
17,588
+2,496
+17% +$186K 0.01% 714
2024
Q4
$1.01M Buy
15,092
+101
+0.7% +$7.07K 0.01% 763
2024
Q3
$1.05M Buy
+14,991
New +$902K 0.02% 561

Other funds holding SOLV

&Partners's SOLV Position: Q1 2026 in Review

&Partners increased its Solventum (SOLV) stake by 17% in Q1 2026, buying an estimated $352K and bringing the position to 32,808 shares worth $2.14M. The position accounts for 0.01% of the portfolio, ranked #868.

&Partners first reported a position in SOLV in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.22M in Q4 2025. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • &Partners held 32,808 shares of Solventum worth $2.14M as of Q1 2026.
  • &Partners bought 4,745 Solventum shares in Q1 2026, an estimated $352K.
  • Solventum made up 0.01% of &Partners's portfolio in Q1 2026, its #868 holding.
  • &Partners first reported a position in Solventum in Q3 2024 and has held it in 7 quarters since.
  • &Partners's Solventum position peaked at $2.22M in Q4 2025.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.